TrialBreast cancer research and treatment2018

Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).

Noam Ponde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.